Strategic Alliances

Graphic: Cathleen Heard Although a smaller percentage of African American women are diagnosed with breast cancer than white women, African Americans are more likely to die from breast cancer than women from other ethnic groups. Vietnamese American women have the highest cervical cancer rates of any ethnic group. And poor Americans of all races have higher rates of cancer incidence and mortality than do people from other socioeconomic groups. The Institute of Medicine's (IOM) report The Une

Written byMyrna Watanabe
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Graphic: Cathleen Heard


Although a smaller percentage of African American women are diagnosed with breast cancer than white women, African Americans are more likely to die from breast cancer than women from other ethnic groups. Vietnamese American women have the highest cervical cancer rates of any ethnic group. And poor Americans of all races have higher rates of cancer incidence and mortality than do people from other socioeconomic groups.

The Institute of Medicine's (IOM) report The Unequal Burden of Cancer1 publicly acknowledged disparities in cancer and cancer mortality rates between the white population in the United States and ethnic minority members and the very poor. But some at the National Institutes of Health note that they have long known about these health disparities.

"I made [health dispartities] a top priority at NIEHS [the National Institute of Environmental Health Sciences] when I arrived in 1991," says NIEHS director Kenneth Olden. He ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies